PT1349855E - Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona - Google Patents

Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona Download PDF

Info

Publication number
PT1349855E
PT1349855E PT01272109T PT01272109T PT1349855E PT 1349855 E PT1349855 E PT 1349855E PT 01272109 T PT01272109 T PT 01272109T PT 01272109 T PT01272109 T PT 01272109T PT 1349855 E PT1349855 E PT 1349855E
Authority
PT
Portugal
Prior art keywords
thiazolidine
pyridyl
ethoxy
benzyl
amino
Prior art date
Application number
PT01272109T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Deirdre O'keeffe
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031528A external-priority patent/GB0031528D0/en
Priority claimed from GB0031526A external-priority patent/GB0031526D0/en
Priority claimed from GB0031524A external-priority patent/GB0031524D0/en
Priority claimed from GB0031521A external-priority patent/GB0031521D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT1349855E publication Critical patent/PT1349855E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT01272109T 2000-12-22 2001-12-21 Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona PT1349855E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0031528A GB0031528D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031526A GB0031526D0 (en) 2000-12-22 2000-12-22 Novel pharmaceuticals
GB0031524A GB0031524D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical
GB0031521A GB0031521D0 (en) 2000-12-22 2000-12-22 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PT1349855E true PT1349855E (pt) 2006-12-29

Family

ID=27447913

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01272109T PT1349855E (pt) 2000-12-22 2001-12-21 Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona

Country Status (12)

Country Link
US (2) US20040082620A1 (pt)
EP (1) EP1349855B1 (pt)
JP (1) JP2004520326A (pt)
KR (1) KR100840846B1 (pt)
CN (1) CN1310912C (pt)
AT (1) ATE337313T1 (pt)
CY (1) CY1106226T1 (pt)
DE (1) DE60122580T2 (pt)
DK (1) DK1349855T3 (pt)
ES (1) ES2270955T3 (pt)
PT (1) PT1349855E (pt)
WO (1) WO2002051839A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
ES2278977T3 (es) * 2001-11-21 2007-08-16 Smithkline Beecham Plc Bencenosulfonato de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona; procedimiento para su preparacion; polimorfos i, ii y iii de los mismos; y su uso como ingrediente activo farmaceutico.
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
EA018427B1 (ru) * 2003-12-16 2013-07-30 Нектар Терапьютикс Химически модифицированный налоксон
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP2062880A1 (en) 2007-11-22 2009-05-27 Bayer Schering Pharma Aktiengesellschaft 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
CA2812649C (en) 2010-09-30 2016-03-01 Astrazeneca Ab Crystalline naloxol-peg conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
EP1349855A1 (en) 2003-10-08
DE60122580D1 (de) 2006-10-05
DE60122580T2 (de) 2007-08-30
CN1310912C (zh) 2007-04-18
EP1349855B1 (en) 2006-08-23
US7291740B2 (en) 2007-11-06
ES2270955T3 (es) 2007-04-16
KR20030064855A (ko) 2003-08-02
CY1106226T1 (el) 2011-06-08
JP2004520326A (ja) 2004-07-08
DK1349855T3 (da) 2006-12-27
WO2002051839A1 (en) 2002-07-04
CN1491224A (zh) 2004-04-21
US20040082620A1 (en) 2004-04-29
US20060040993A1 (en) 2006-02-23
KR100840846B1 (ko) 2008-06-23
ATE337313T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
HUP0300158A3 (en) Hydrochloride salts of-5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, method for their production and pharmaceutical compositions containing them
IL155036A0 (en) Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1562A (en) Thiazolidinedione derivatives and its use as antidiabetic.
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
GB0021978D0 (en) Novel pharmaceutical
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona